Zhu Xiaofei, Yue Haodi, Guo Xiaofang, Yang Jingyi, Liu Jingshuo, Liu Jiangtao, Wang Ruijie, Zhu Wenjuan
Department of Clinical Immunology, Research Center for Immunology, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang 453003, China.
Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Xinxiang 453003, China.
Oxid Med Cell Longev. 2017;2017:2391820. doi: 10.1155/2017/2391820. Epub 2017 Jul 2.
With a long history of application in Chinese traditional medicine, berberine (BBR) was reported to exhibit healthspan-extending properties in some age-related diseases, such as type 2 diabetes and atherosclerosis. However, the antiaging mechanism of BBR is not completely clear. By means of hydrogen peroxide- (HO-) induced premature cellular senescence model, we found that a low-concentration preconditioning of BBR could resist premature senescence in human diploid fibroblasts (HDFs) measured by senescence-associated -galactosidase (SA--gal), accompanied by a decrease in loss of mitochondrial membrane potential and production of intracellular reactive oxygen species (ROS). Moreover, the low-concentration preconditioning of BBR could make cells less susceptible to subsequent HO-induced cell cycle arrest and growth inhibition. Experimental results further showed that the low concentration of BBR could induce a slight increase of ROS and upregulate the expression level of sirtuin 1 (SIRT1), an important longevity regulator. HO-induced activation of checkpoint kinase 2 (Chk2) was significantly attenuated after the preconditioning of BBR. The present findings implied that the low-concentration preconditioning of BBR could have a mitohormetic effect against cellular senescence triggered by oxidative stress in some age-related diseases through the regulation of SIRT1.
黄连素(BBR)在中国传统医学中有着悠久的应用历史,据报道,它在某些与年龄相关的疾病,如2型糖尿病和动脉粥样硬化中具有延长健康寿命的特性。然而,BBR的抗衰老机制尚不完全清楚。通过过氧化氢(H₂O₂)诱导的细胞早衰模型,我们发现低浓度预处理的BBR可以抵抗人二倍体成纤维细胞(HDFs)的早衰,这通过衰老相关β-半乳糖苷酶(SA-β-gal)检测得出,同时伴随着线粒体膜电位丧失和细胞内活性氧(ROS)生成的减少。此外,低浓度预处理的BBR可以使细胞对随后H₂O₂诱导的细胞周期阻滞和生长抑制更不敏感。实验结果进一步表明,低浓度的BBR可以诱导ROS略有增加,并上调重要的长寿调节因子沉默调节蛋白1(SIRT1)的表达水平。BBR预处理后,H₂O₂诱导的检查点激酶2(Chk2)激活显著减弱。目前的研究结果表明,低浓度预处理的BBR可能通过调节SIRT1对某些与年龄相关疾病中氧化应激引发的细胞衰老具有线粒体应激效应。